Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial.

Menezes MD, McCarter R, Greene EA, Bauman NM.

Ann Otol Rhinol Laryngol. 2011 Oct;120(10):686-95. Review.

PMID:
22097156
2.

Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.

Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, He J, Greene EA, Puttgen KB.

JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):323-30. doi: 10.1001/jamaoto.2013.6723.

PMID:
24526257
3.

Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.

Kim KH, Choi TH, Choi Y, Park YW, Hong KY, Kim DY, Choe YS, Lee H, Cheon JE, Park JB, Park KD, Kang HJ, Shin HY, Jeong JH.

JAMA Dermatol. 2017 Jun 1;153(6):529-536. doi: 10.1001/jamadermatol.2017.0250.

PMID:
28423174
4.

Propranolol and infantile hemangiomas four years later: a systematic review.

Marqueling AL, Oza V, Frieden IJ, Puttgen KB.

Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91. doi: 10.1111/pde.12089. Epub 2013 Feb 14. Review.

PMID:
23405852
5.

Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas.

Cushing SL, Boucek RJ, Manning SC, Sidbury R, Perkins JA.

Otolaryngol Head Neck Surg. 2011 Jan;144(1):78-84. doi: 10.1177/0194599810390445.

PMID:
21493392
6.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ.

N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.

7.

Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.

Hermans DJ, Bauland CG, Zweegers J, van Beynum IM, van der Vleuten CJ.

Br J Dermatol. 2013 Apr;168(4):837-43. doi: 10.1111/bjd.12189.

PMID:
23278381
8.

The role of propranolol in the treatment of infantile hemangioma.

Laranjo S, Costa G, Paramés F, Freitas I, Martins JD, Trigo C, Pinto FF.

Rev Port Cardiol. 2014 May;33(5):289-95. doi: 10.1016/j.repc.2013.10.018. Epub 2014 Jun 4.

PMID:
24906291
9.

[Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].

Yilmaz L, Dangoisse C, Semaille P.

Rev Med Brux. 2015 Jan-Feb;36(1):3-9. French.

PMID:
25856965
10.

A randomized controlled trial of propranolol for infantile hemangiomas.

Hogeling M, Adams S, Wargon O.

Pediatrics. 2011 Aug;128(2):e259-66. doi: 10.1542/peds.2010-0029. Epub 2011 Jul 25.

PMID:
21788220
11.

Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review.

Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, Gautier S, Ortis V, Lafon M, Montagne A, Delarue A, Voisard JJ.

Pediatrics. 2016 Oct;138(4). pii: e20160353. Review.

PMID:
27688361
12.

Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.

Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D.

JAMA Otolaryngol Head Neck Surg. 2013 Oct;139(10):1026-31. doi: 10.1001/jamaoto.2013.4773.

PMID:
24135743
13.

Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.

Schupp CJ, Kleber JB, Günther P, Holland-Cunz S.

Pediatr Dermatol. 2011 Nov-Dec;28(6):640-4. doi: 10.1111/j.1525-1470.2011.01569.x. Epub 2011 Oct 13.

PMID:
21995836
14.

A novel topical nano-propranolol for treatment of infantile hemangiomas.

Chen ZG, Zheng JW, Yuan ML, Zhang L, Yuan WE.

Nanomedicine. 2015 Jul;11(5):1109-15. doi: 10.1016/j.nano.2015.02.015. Epub 2015 Mar 16.

PMID:
25791814
15.

Late rebound of infantile hemangioma after cessation of oral propranolol.

Shehata N, Powell J, Dubois J, Hatami A, Rousseau E, Ondrejchak S, McCuaig C.

Pediatr Dermatol. 2013 Sep-Oct;30(5):587-91. doi: 10.1111/pde.12190.

PMID:
24016283
17.

Use of propranolol in infantile haemangioma among Chinese children.

Chik KK, Luk CK, Chan HB, Tan HY.

Hong Kong Med J. 2010 Oct;16(5):341-6.

18.

[Oral propranolol in the management of periorbital proliferating phase infantile hemangioma].

Zhao ZF, Lü RR, Zhang J, Huo R, Xu GQ, Fu HB, Guo X, Wui JC, Lin LL.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2011 May;27(3):174-7. Chinese.

PMID:
21837994
19.

Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study.

Malik MA, Menon P, Rao KL, Samujh R.

J Pediatr Surg. 2013 Dec;48(12):2453-9. doi: 10.1016/j.jpedsurg.2013.08.020.

PMID:
24314186
20.

Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.

Ma X, Zhao T, Xiao Y, Yu J, Chen H, Huang Y, Liu J, Lin J, Ouyang T.

Eur J Pediatr. 2013 May;172(5):653-9. doi: 10.1007/s00431-012-1928-9. Epub 2013 Jan 23.

PMID:
23340697

Supplemental Content

Support Center